Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
												
			
			| (One intermediate revision not shown.) | |||
| Line 29: | Line 29: | ||
| **Autoimmune Diseases | **Autoimmune Diseases | ||
| ***[[Prolyl Endopeptidase]] | ***[[Prolyl Endopeptidase]] | ||
| - | ***[[Tumor  | + | ***[[Tumor necrosis factor receptor]] | 
| ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
| Line 88: | Line 88: | ||
| *** Poliovirus | *** Poliovirus | ||
| ****[[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | ****[[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | ||
| + | *** [[Interferon]] | ||
| }} | }} | ||
| See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | ||
Current revision
The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.
See Pharmaceutical Drugs for descriptions and analysis of well known drugs
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
